TIANFUCHEM--557795-19-4---Sunitinib CAS NO.557795-19-4
- FOB Price: USD: 500.00-500.00 /Metric Ton Get Latest Price
- Min.Order: 1 Metric Ton
- Payment Terms: L/C,T/T
- Available Specifications:
1(1-2)Metric Ton
- Product Details
Keywords
- TIANFUCHEM--557795-19-4---Sunitinib
- TIANFUCHEM--557795-19-4---Sunitinib
- TIANFUCHEM--557795-19-4---Sunitinib
Quick Details
- ProName: TIANFUCHEM--557795-19-4---Sunitinib
- CasNo: 557795-19-4
- Molecular Formula: C26H31FN4O6
- Appearance: white powder
- Application: Pharmaceutical intermediates
- DeliveryTime: in stock
- PackAge: bag
- Port: China main port
- ProductionCapacity: 1 Metric Ton/Day
- Purity: 99%
- Storage: Room temperature
- Transportation: by sea
- LimitNum: 1 Metric Ton
- Heavy metal: N/A
- Grade: Industrial Grade
- Transportation: N/A
Superiority
Our company was built in 2009 with an ISO certificate.In the past 6 years, we have grown up as a famous fine chemicals supplier in China and we had established stable business relationships with Samsung,LG,Merck,Thermo Fisher Scientific and so on.Our main business covers the fields below:
1.Noble Metal Catalysts (Pt.Pd...)
2.Organic Phosphine Ligands (Tert-butyl-phosphine.Cyclohexyl-phosphine...)
3.OLED intermediates (Fluorene,Carbazole,Boric acid...)
4.Customs Synthesis
Our advantage:
1. Higest quality and good package
2.Fast delivery
3.Better payment term
4.Fast response to customer within 6 hours
5.Good business credit in Europe ,US ,Japan ,Korea
Anyway ,if you need any chemicals from China ,Henan Tianfu can help you
Details
Product Name:SunitinibSynonyms:Sunitinib--- free base;Sunitinib,Sutent;5-(5-Fluoro-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid N-(2-diethylaminoethyl)amide;Suniti;N-[2-(diethylaMino)ethyl]-5-{[(3Z)-5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidene]Methyl}-2,4-diMethyl-1H-pyrrole-3-carboxaMide;N-[2-DiethylaMino(ethyl-d4)]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-2,4-diMethyl-1H-pyrrole-3-carboxaMide;SU-11248-d4;Sutent-d4CAS:557795-19-4MF:C26H31FN4O6MW:514.55EINECS:Product Categories:Tyrosine Kinase Inhibitors;Pharmaceutical intermediate;API;Isotope Labelled Compounds;SU-11248;Inhibitors;Active Pharmaceutical Ingredients;Sunitinib;Molecular Targeted Antineoplastic;Heterocyclic Compounds;anti-neoplastic;Heterocycles;Intermediates & Fine Chemicals;PharmaceuticalsMol File:557795-19-4.mol
Sunitinib Chemical Properties
Melting point 189-191°Cdensity 1.2Fp 299.8℃pka8.5(at 25℃)CAS DataBase Reference557795-19-4(CAS DataBase Reference)
Safety Information
Safety Statements 24/25
MSDS Information
Sunitinib Usage And Synthesis
Chemical PropertiesYellow SolidUsesA multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK). AntineoplasticUsesSunitinib Malate (Sutent, SU11248) is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.UsesSunitinib Malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.UsesLabelled Sunitinib (S820000), a multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK).UsesLabelled Sunitinib, a multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK).
Sunitinib Chemical Properties
Melting point 189-191°Cdensity 1.2Fp 299.8℃pka8.5(at 25℃)CAS DataBase Reference557795-19-4(CAS DataBase Reference)
Safety Information
Safety Statements 24/25
MSDS Information
Sunitinib Usage And Synthesis
Chemical PropertiesYellow SolidUsesA multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK). AntineoplasticUsesSunitinib Malate (Sutent, SU11248) is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.UsesSunitinib Malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.UsesLabelled Sunitinib (S820000), a multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK).UsesLabelled Sunitinib, a multi-kinase inhibitor targeting several receptor tyrosine kinases (RTK).